Skip to search formSkip to main contentSkip to account menu

MCI 225

Known as: MCI-225 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PiperazinesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
The anxiolytic-like effect of MCI-225, a selective NA reuptake inhibitor with 5-HT3 receptor antagonism
Review
2001
Review
2001
[Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
Pharmacology, clinical efficacy and tolerability of serotonin noradrenaline reuptake inhibitors(SNRIs) are overviewed. They… 
2000
2000
Effects of acute and chronic administration of MCI-225, a new selective noradrenaline reuptake inhibitor with 5-HT3 receptor blocking action, on extracellular noradrenaline levels in the hypothalamus…
In the present study, we investigated the effects of acute and chronic systemic administration of MCI-225 (4-(2-fluorophenyl)-6… 
1997
1997
Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride.
This is a first report on the investigation of the antidepressant activity of MCI-225 (4-(2-fluorophenyl)-6-methyl-2-(1… 
1997
1997
MCI-225, A Novel Thienopyrimidine Analog, Enhances Attentional Eye Tracking in Midpontine Pretrigeminal Preparation
1995
1995
Effects of MCI-225 on memory and glucose utilization in basal forebrain-lesioned rats
1994
1994
Effects of a novel compound MCI-225 on impaired learning and memory in rats
1993
1993
Effect of a new psychoactive compound, MCI-225, on brain monoamine metabolism in rats.
Effect of MCI-225 on brain monoamine metabolism was examined in rats. MCI-225 (30 mg/kg, p.o.) had no influence on noradrenaline… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)